agilon health turned in a stronger Q1 after a brutal FY2025 reset, but the thesis still depends on whether member exits, payor discipline, ACO contribution and CEO execution can hold up against Medicare Advantage medical-cost trend.
References
Sources used in this report
SEC datasetSEC company tickers exchange datasetRetrieved 2026-05-14 · Issuer identity, ticker, exchange and CIK cross-check.SEC APIAGL submissions APIRetrieved 2026-05-14 · Filing chronology and latest company filings.Quarterly reportQ1 2026 Form 10-Q2026-05-06 · Latest business description, balance sheet, liquidity, VIEs, credit facility and risks.Earnings releaseQ1 2026 earnings release2026-05-06 · Q1 revenue, membership, medical margin, adjusted EBITDA, cash, debt and updated 2026 guidance.Annual reportFY2025 Form 10-K2026-02-25 · Business model, revenue recognition, medical claims estimates, NYSE notice, VIEs and litigation.Earnings releaseQ4 and FY2025 earnings release2026-02-25 · FY2025 revenue, member counts, medical margin, adjusted EBITDA loss, cash and debt.Investor presentationFY2025 investor presentation2026-02-25 · Management bridge to 2026 guidance, cost reductions, payor exits, Stars and medical cost assumptions.Governance filing2026 proxy statement2026-04-22 · Board, CD&R governance rights, CEO transition, ownership and compensation context.Current reportCEO appointment current report2026-04-27 · Tim O'Rourke appointment, employment terms and director appointment.Company press releaseReverse stock split press release2026-03-18 · 1-for-25 reverse split rationale and NYSE compliance context.Regulator sourceCMS ACO REACH model fact sheetRetrieved 2026-05-14 · ACO REACH program goals, risk-sharing options and beneficiary protections.Regulator sourceCMS Shared Savings Program pageRetrieved 2026-05-14 · MSSP ACO context and shared-savings framework.